-
Expanding Global Protection: Genprex Secures Key Patent for Reqorsa® Gene Therapy in Israel
NASDAQ: $GNPX In a significant move to strengthen its international intellectual property portfolio, clinical-stage gene therapy company Genprex, Inc. (NASDAQ: GNPX) recently announced that the Israel Patent Office (ILPO) has officially granted a patent covering the use of its proprietary Reqorsa® gene therapy (quaratusugene ozeplasmid) in combination with PD-1 antibodies for cancer treatment. Strategic Intellectual…
-
Pharos AI and 10x Genomics Join Forces to Advance Cancer Research Through Integrated Technology
NASDAQ: $TXG A significant collaboration has been established between Pharos AI, a leader in artificial intelligence solutions for the life sciences, and 10x Genomics, a pioneer in single cell and spatial biology technologies. This partnership is set to revolutionize how researchers approach complex challenges in oncology by integrating advanced computational power with cutting-edge molecular analysis.…